MARKET

ZSAN

ZSAN

Zosano Pharma Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.110
+0.175
+9.04%
After Hours: 2.170 +0.06 +2.84% 17:43 05/19 EDT
OPEN
1.920
PREV CLOSE
1.935
HIGH
2.190
LOW
1.920
VOLUME
120.63K
TURNOVER
0
52 WEEK HIGH
37.45
52 WEEK LOW
1.330
MARKET CAP
10.34M
P/E (TTM)
-0.2251
1D
5D
1M
3M
1Y
5Y
BRIEF-Emergex Vaccines Announces Successful Coating Of Its COVID-19 Vaccine Onto Zosano Pharma's Micro-Needle Patch
reuters.com · 2d ago
Zosano Pharma: Q1 Earnings Insights
Zosano Pharma (NASDAQ:ZSAN) reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75.
Benzinga · 6d ago
BRIEF-Zosano Pharma Says Board Approved Decreasing Size Of Board To Five Members
reuters.com · 6d ago
BRIEF-Zosano Pharma Q1 Loss Per Share $7.86
reuters.com · 6d ago
Zosano Pharma  GAAP EPS of -$7.86 misses by $7.81, revenue of $0.14M beats by $0.04M
Zosano Pharma  press release (NASDAQ:ZSAN): Q1 GAAP EPS of -$7.86 misses by $7.81. Revenue of $0.14M (-46.2% Y/Y) beats by $0.04M.
Seekingalpha · 6d ago
Zosano Pharma Tumbles After-Hours on Going Concern Warning, Higher Q1 Loss
MT Newswires · 6d ago
Zosano Pharma's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million.
Benzinga · 05/09 13:49
Zosano Pharma Corporation (ZSAN) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Zosano Pharma Corporation (ZSAN) closed at $1.70, marking a +0.59% move from the previous day.
Zacks · 05/03 21:50
More
No Data
Learn about the latest financial forecast of ZSAN. Analyze the recent business situations of Zosano Pharma Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ZSAN stock price target is 21.00 with a high estimate of 21.00 and a low estimate of 21.00.
High21.00
Average21.00
Low21.00
Current 2.110
EPS
Actual
Estimate
-2.14-1.61-1.07-0.54
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 46
Institutional Holdings: 1.01M
% Owned: 20.57%
Shares Outstanding: 4.90M
TypeInstitutionsShares
Increased
1
12
New
1
280
Decreased
0
0
Sold Out
2
2.58K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.00%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
President/Chief Executive Officer/Director
Steven Lo
Chief Financial Officer
Christine Matthews
Vice President
Donald Kellerman
Lead Director/Independent Director
Kenneth Greathouse
Director
Kathy McGee
Director
Elaine Yang
Independent Director
Linda Grais
No Data
No Data
About ZSAN
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The Company is focused on providing systemic administration of therapeutics to patients using its ransdermal microneedle system (the System). The System is designed to facilitate drug absorption into the bloodstream. The Company’s lead product candidate is Qtrypta (M207). Qtrypta is a formulation of zolmitriptan delivered utilizing its System. Zolmitriptan is a serotonin receptor agonists known as triptans and is used as an acute treatment for migraine. Qtrypta is designed for absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal (GI) tract. Its same formulation, development name C213, is the treatment to provide relief for cluster headache.

Webull offers kinds of Zosano Pharma Corp stock information, including NASDAQ:ZSAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZSAN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZSAN stock methods without spending real money on the virtual paper trading platform.